Synthesizing DPP-IV Inhibitor Intermediate via Protecting Group Strategy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing compound of formula (2) as an intermediate for synthesizing DPP-IV inhibitor compound of formula (1) face challenges in achieving high optical purity due to racemization, which affects the purity of the final compound.

Innovation Solution

A novel method involving specific reaction steps, including coupling, cyclization, and hydrolysis of compounds of formulas (4) and (5), with the use of appropriate protecting groups and solvents, to produce compound of formula (2) with high optical purity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If the compound of formula (2) is prepared by the method disclosed in WO 06/104356, then the compound can be obtained, but the optical purity is reduced due to racemization of the stereogenic center

Engineering Contradiction:
Improveoptical purityVSAvoidstability of stereogenic center
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The invention applies preliminary protection action by introducing a protecting group (P¹) to the amine group before the coupling reaction. This preliminary protection prevents racemization of the stereogenic center during the synthesis process, thereby maintaining high optical purity of the final compound (2). The protecting group is removed only after the coupling is complete, ensuring the stereocenter remains stable throughout the critical reaction steps.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If mass-scale production is conducted using the prior method, then production volume increases, but optical purity decreases due to racemization

Engineering Contradiction:
Improveproduction volumeVSAvoidoptical purity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The protecting group strategy is implemented at the beginning of the synthesis process, before mass-scale production begins. This preliminary action of protecting the amine group ensures that even during large-scale production with extended reaction times and higher concentrations, racemization is prevented, allowing high optical purity to be maintained throughout mass production.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention changes the chemical environment parameters by introducing the protecting group, which alters the reactivity and stability characteristics of the intermediate compounds. This parameter change (adding the protecting group) enables the reaction conditions to be optimized for mass production while maintaining optical purity, as the protected intermediate is less prone to racemization under production-scale conditions.

Inventive Principle:
Principle #35Parameter changes

3Device complexity

If the amine group is left unprotected during coupling reaction, then the synthesis is simpler, but racemization occurs at the stereogenic center

Engineering Contradiction:
Improvesynthesis complexityVSAvoidoptical purity
Core Design Contradiction:
Device complexityVSManufacturing precision

Solution Approach 1:

The amine group is protected in advance with a protecting group (P¹) before the coupling reaction takes place. This preliminary protection step, while adding one operation to the synthesis, prevents racemization during the coupling process. The protecting group is then removed in a final step, resulting in a systematic but reliable synthesis route that maintains high optical purity.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The protecting group acts as an intermediary that temporarily modifies the amine group to prevent unwanted side reactions and racemization. This intermediary structure allows the coupling reaction to proceed cleanly without compromising the stereogenic center, and is subsequently removed to reveal the desired product with high optical purity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method effectively produces compound of formula (2) with high optical purity, ensuring the subsequent compound of formula (1) has high optical purity, suitable for medical use as a DPP-IV inhibitor.

Implementation Method 1

the step of coupling reaction by addition of a base to the compound of formula (4) and the compound of formula (5)

Methodology Applied
Scientific EffectCoupling reaction: Chemical Bonding

Implementation Method 2

the step of cyclization by addition of an acid to obtain the compound of formula (2a)

Methodology Applied
Scientific EffectCyclization: Chemical Bonding

Implementation Method 3

the step of removing the carboxylic acid protecting group by hydrolysis of the resulting compound of formula (2a) to obtain the compound of formula (2)

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentEP2611776B1Production method of intermediate compound for synthesizing medicament
Publication Date: 2016.09.21 LG LIFE SCI LTD
  • EP2611776B1 patent drawing
  • EP2611776B1 patent drawing
  • EP2611776B1 patent drawing

AI summary

The present invention relates to a novel method for preparing a compound of formula (2) as the intermediate, which can be effectively used for preparation of a compound of formula (1) exhibiting good inhibitory activity against dipeptidyl peptidase IV enzyme.